CERo Therapeutics Holdings Inc (CERO)
0.93
-0.03
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
0.911
-0.02
(-2.04%)
After-Hours: 20:00
CERo Therapeutics Holdings Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -2.438M |
Date | Value |
---|---|
March 31, 2022 | -3.515M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.515M
Minimum
Mar 2022
-2.438M
Maximum
Mar 2023
-2.977M
Average
-2.977M
Median
Net Income (Quarterly) Benchmarks
Ainos Inc | -3.315M |
Mind Medicine Inc | -54.40M |
Ventyx Biosciences Inc | -38.57M |
Avid Bioservices Inc | -6.006M |
Creative Medical Technology Holdings Inc | -1.042M |